Learn more

BAXTER AG

Overview
  • Total Patents
    440
  • GoodIP Patent Rank
    225,340
About

BAXTER AG has a total of 440 patent applications. Its first patent ever was published in 1987. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN, TOCAGEN INC and ID LELYSTAD INST DIERHOUDERIJ.

Patent filings per year

Chart showing BAXTER AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Dorner Friedrich 120
#2 Eibl Johann 105
#3 Schwarz Hans-Peter 102
#4 Turecek Peter 99
#5 Linnau Yendra 54
#6 Mitterer Artur 40
#7 Mundt Wolfgang 35
#8 Schlokat Uwe 35
#9 Fischer Bernhard 29
#10 Falkner Falko-Guenter 27

Latest patents

Publication Filing date Title
JP2014223078A Stable recombinant cell clones, production and use thereof
JP2010279739A Method for producing preparation based on fibrinogen and fibronectin, and protein composition obtainable according to this method
JP2011004754A Recombinant stabilized cell clone, production thereof, and use thereof
JP2010099093A Recombinant stable cell clone, and production and use thereof
JP2010110327A Quality assured biological sample and method for producing composition containing the same
ZA200304741B Von willebrand factor (vWF) cleaving protease polypeptide, nucleic acid encoding the polypeptide and use of polypeptide.
AU1051702A Xenogeneic antibody containing plasma reagents and associated methods
AU1045702A Metal-free washing device
US6465170B2 Method for depleting viral and molecular pathogens in a biological material
US6926894B2 Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
US2002137039A1 5' Nuclease nucleic acid amplification assay having an improved internal control
US6506365B1 Fibrin/fibrinogen binding conjugate
US6596526B1 Furin polypeptides with improved characteristics
AU3133600A Test kit for analysing factor VIII-splitting protease
AU3133400A Syringe
AU2804100A A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method
ATA217099A Method for detecting and quantifying nucleic acids in a sample
ATA216599A Method for detecting, distinating and quantifying free and enclosed nucleic acids in a sample
ATA216699A Method for producing a c1-esterase inhibitor (c1-inh) composition
ATA216499A Method of determining antigens in a sample